Article
Urinary Metabolites and Survival in Malignant Mesothelioma
2025-09-25
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Malignant mesothelioma is a rare and aggressive malignancy with limited treatment options and poor survival outcomes. Current biomarkers such as MESOMARK, fibulin-3, and osteopontin show diagnostic potential but remain hampered by inconsistent sensitivity and reproducibility. Urine-based metabolites may provide a simple, noninvasive alternative for prognosis and disease moni...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 765bf741-6c5f-532e-8882-10690d3bab18
- DOI
- 10.1101/2025.09.23.25336488
